recombinant interferon alfa-2b
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for recombinant interferon alfa-2b, covering 2018-10-29 to 2022-03-02. Get the full timeline:
Most recent: Clinical Trial Update: Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver [Phase 2]